MUC16 and ovarian carcinoma: It acts as a precursor for CA125, most widely used serum biomarker for ovarian cancer (OC), that are located as the repetitive peptide epitopes in the large glycosylated N-terminal region of MUC16, therefore, is of high clinical importance [16].